Approval · Notice of Compliance 6097 · 2002
COMPONENT E-H IMPLANTS WITH TYLAN: Notice of Compliance 6097
Issued May 21, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6097
- Date
- May 21, 2002
- Company
- Ivy Animal Health, Inc.
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Growth promotant and antibacterial
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMPONENT E-H IMPLANTS WITH TYLAN | 02245746 | Marketed |
Medicinal ingredients
- TESTOSTERONE PROPIONATE 200 MG per DOSE
- ESTRADIOL BENZOATE 20 MG per DOSE
- TYLOSIN TARTRATE 29 MG per DOSE